Doosan Portable Power Donates to Susan G. Komen for the Cure

03/27/2013

STATESVILLE, N.C. - Doosan Portable Power recently donated $4,000 to Susan G. Komen for the Cure®, Charlotte Affiliate. Susan G. Komen is the leading breast cancer awareness and research organization in the U.S.

The donation is part of a broader effort by Doosan Portable Power to support Susan G. Komen and efforts to increase breast cancer awareness. In 2011, Doosan Portable Power created a line of pink products - a P185 air compressor, G25 mobile generator, and LSC light tower - which dealers had the opportunity to purchase in support of the cause. Doosan Portable Power also offers a line of pink merchandise with 10 percent of proceeds benefiting Susan G. Komen for the Cure. To date, Doosan Portable Power donations have totaled more than $10,000.

“We have so much appreciation for our community, and we consider it our responsibility to give back to those organizations that are helping increase the quality of life for our community members,” said Shawn Sweet, president of Doosan Portable Power. “The individuals at Susan G. Komen are at work every day to ensure brighter, healthier futures for our mothers, sisters, aunts, friends; we are humbled by the opportunity to provide resources to such a great organization.”

Doosan Portable Power provides products of the highest quality and reliability in all major global markets. The product lineup includes mobile generators, air compressors, light towers and light compaction equipment. Doosan Portable Power has been headquartered in Statesville, N.C., since 2007 and employs over 500 people.

The Susan G. Komen for the Cure, Charlotte Affiliate, is a grant-making organization. Between April 2012 and March 2013, the Charlotte Affiliate provided $1.4 million in grants, supporting local programs that provide screening, education and treatment to women and men in its nine-county service area. Also, 25 percent of Komen’s income supports ground-breaking breast cancer research studies, many of which are currently underway in North Carolina at UNC-Chapel Hill, Wake Forest University and Duke.